Calliope · Life Sciences Advisory
Connecting Expertiseto Advance Science.
Strategic advisory for life sciences organizations navigating complex scientific, clinical, regulatory and organizational decisions.
About Calliope
Advancing science requires more than scientific expertise.
Moving promising science forward requires the right development strategy, clinical expertise, regulatory insight, organizational capabilities and connections.
We help life sciences organizations bring these elements together to navigate complex decisions and advance their programs.
Calliope is a life sciences strategic advisory firm that helps organizations advance scientific innovation by connecting the people, expertise and capabilities required to navigate scientific development, clinical programs, regulatory pathways and organizational growth. Founded by Dr. Launa Aspeslet, the firm draws on decades of senior leadership experience across biotechnology, pharmaceuticals and clinical research.
Who we serve
- 01Biotechnology companies
- 02Pharmaceutical companies
- 03Emerging life sciences companies
- 04Medical device & health technology companies
- 05Academic & research organizations
- 06Life sciences investors
- 07Boards & executive teams
- 08Strategic partners
The Translational Pathway
One continuous strategy, from first insight to global scale.
Select a stage to see where programs most often stall — and where senior advisory changes the trajectory.
Stage 01 — Where science meets strategy
Compelling science is the entry ticket, not the strategy. At discovery, the decisions that matter most are which programs to advance, which to pause, and what evidence will actually persuade regulators, clinicians and investors downstream. Connecting the right translational expertise at this stage shapes everything that follows.
Critical activities
- —Target & lead validation
- —Translational assessment
- —Portfolio prioritization
- —Development pathway mapping
Where we intervene
- —Translational development strategy
- —Portfolio strategy
- —Development risk assessment
Founder Career Experience
Experience across the entire translational pathway.
The judgment behind Calliope's advisory practice was earned in the operating seat — leading programs, organizations and boards through every stage of development.
0+
Years in life sciences
Executive leadership across biotech, pharma and clinical research
0+
Clinical trials
Programs spanning early-phase through pivotal development
0+
Patients
Enrolled across clinical programs under her leadership
0+
Countries
Global clinical and regulatory operations
0+
Employees led
Organizational scaling at global scale
Figures reflect Dr. Aspeslet's executive career experience prior to founding Calliope.
Advisory Services
Five practices. One integrated point of view.
Engagements are scoped to the decision at hand — from a single board question to a full development-to-submission strategy.
Founder & CEO
Dr. Launa Aspeslet, PhD
Meet Dr. Launa Aspeslet
An operator's judgment, earned in the operating seat.
Dr. Launa Aspeslet founded Calliope to connect the people, expertise and capabilities life sciences organizations need to move promising science forward. She is a senior executive, strategic advisor and board leader with nearly three decades of experience across biotechnology, pharmaceuticals and clinical research — spanning scientific development, clinical programs, regulatory pathways and organizational growth.
She has guided products from early-stage research through clinical development and global regulatory review, led hundreds of health authority interactions across major markets, and scaled a clinical research organization to operations in more than 20 countries with a team of over 300. Calliope brings that operator's perspective to founders, executives, investors and boards facing consequential decisions.
Manifesto
The Calliope manifesto.
Science advances through connection
Moving promising science forward takes more than scientific expertise — it takes development strategy, clinical insight, regulatory understanding and organizational capability, connected and working as one.
The right expertise, at the right decision
The hardest decisions in life sciences are made between the milestones. Connecting the right people and judgment at exactly those moments is what changes a program's trajectory.
Judgment compounds
Senior perspective applied early — when the cost of being wrong is still low — is the highest-leverage investment a life sciences organization can make.
Insights
Thinking from the translational front line.
Perspectives on leadership, development strategy, regulatory pathways and the organizational side of bringing science to patients.
Begin the Conversation
Have a complex life sciences challenge?
Let's discuss the path forward.
Share a few details about your program, organization or decision at hand. Every enquiry is reviewed personally, and you can expect a considered response — not an automated one.
Edmonton, AB, Canada · Global
info@calliopeadvisory.ca